In-Home COVID-19 Testing for Children With Medical Complexity: Feasibility and Association With School Attendance and Safety Perceptions.
Am J Public Health
; 112(S9): S878-S882, 2022 11.
Article
en En
| MEDLINE
| ID: mdl-36108256
ABSTRACT
The REstarting Safe Education and Testing program for children with medical complexity was implemented in May 2021 at the University of Wisconsin to evaluate the feasibility of in-home rapid antigen COVID-19 testing among neurocognitively affected children. Parents or guardians administered BinaxNOW rapid antigen self-tests twice weekly for three months and changed to symptom and exposure testing or continued surveillance. In-home testing was feasible nearly all (92.5%) expected tests were conducted. Symptomatic testing identified seven of nine COVID-19 cases. School safety perceptions were higher among those opting for symptom testing. Clinical Trials.gov identifier NCT04895085. (Am J Public Health. 2022;112(S9)S878-S882. https//doi.org/10.2105/AJPH.2022.306971).
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Prueba de COVID-19
/
COVID-19
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Child
/
Humans
Idioma:
En
Revista:
Am J Public Health
Año:
2022
Tipo del documento:
Article